<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>&#187; Visualase</title>
	<atom:link href="http://www.visualaseinc.com/tag/focal-ablation/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.visualaseinc.com</link>
	<description></description>
	<lastBuildDate>Wed, 25 Jan 2012 15:41:10 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.5</generator>
		<item>
		<title>Urology: MRI–guided focal laser ablation in Prostate</title>
		<link>http://www.visualaseinc.com/2010/prostate-focal-ablation-mri/</link>
		<comments>http://www.visualaseinc.com/2010/prostate-focal-ablation-mri/#comments</comments>
		<pubDate>Wed, 17 Mar 2010 17:48:07 +0000</pubDate>
		<dc:creator>visualase</dc:creator>
				<category><![CDATA[In the news]]></category>
		<category><![CDATA[Laser Ablation]]></category>
		<category><![CDATA[Urology]]></category>
		<category><![CDATA[(MRI)–guided focal laser ablation]]></category>
		<category><![CDATA[focal ablation]]></category>
		<category><![CDATA[laser ablation]]></category>
		<category><![CDATA[magnetic resonance imaging]]></category>
		<category><![CDATA[thermometry]]></category>

		<guid isPermaLink="false">http://www.visualaseinc.com/?p=656</guid>
		<description><![CDATA[Study in the news Real-Time Magnetic Resonance Imaging–Guided Focal Laser (Ablation) in Patients with Low-Risk Prostate Cancer Orit Raz, Masoom A. Haider, Sean R.H. Davidson, Uri Lindner, Eugen Hlasny, Robert Weersink, Mark R. Gertner, Walter Kucharcyzk, Stuart A. McCluskey, John Trachtenberg. Accepted 3 March 2010, Published online 12 March 2010 (Posted on www.europeanurology.com) Excerpts below: [...]]]></description>
			<content:encoded><![CDATA[<p>Study in the news</p>
<h3>Real-Time Magnetic Resonance Imaging–Guided Focal Laser (Ablation) in Patients with Low-Risk Prostate Cancer</h3>
<address>Orit Raz, Masoom A. Haider,  Sean R.H. Davidson,  Uri Lindner<a id="back-aff1" href="http://www.europeanurology.com/article/S0302-2838%2810%2900224-1/#aff1"></a>,  Eugen Hlasny<a id="back-aff2" href="http://www.europeanurology.com/article/S0302-2838%2810%2900224-1/#aff2"></a>,  Robert Weersink,  Mark R. Gertner<a id="back-aff3" href="http://www.europeanurology.com/article/S0302-2838%2810%2900224-1/#aff3"></a>,  Walter Kucharcyzk,  Stuart A. McCluskey<a id="back-aff4" href="http://www.europeanurology.com/article/S0302-2838%2810%2900224-1/#aff4"></a>,  John Trachtenberg<a id="back-aff1" href="http://www.europeanurology.com/article/S0302-2838%2810%2900224-1/#aff1"></a>.</address>
<address>Accepted 3 March 2010, Published online  12 March 2010</address>
<address>(Posted on www.europeanurology.com)</address>
<p>Excerpts below:</p>
<blockquote>
<h3>Abstract</h3>
<p>The tumor was  identified on MRI. A laser fiber was delivered via a catheter inserted  through a perineal template and guided to the target with MRI. The  tissue temperature was monitored during laser ablation by MRI  thermometry. Accumulated thermal damage was calculated in real time.  Immediate post-procedure contrast-enhanced MRI confirmed  devascularization of the target. No adverse events were noted.  MRI-guided focal laser (ablation) of low-risk PCa is feasible and may offer  a good balance between cancer control and side effects.</p></blockquote>
<p><span id="more-656"></span></p>
<blockquote><p>Once the catheter reached its target, the metal trocar was  replaced by an optical fiber with a 1-cm-long cylindrically diffusing  tip attached to a 980-nm diode laser (<a title="Focal ablation in prostate" href="../" target="_blank">Visualase</a> Inc, Houston, TX, USA).</p>
<p>During laser ablation, temperature was measured simultaneously on  five 3-mm-thick image slices that covered the target volume (Fig.  5a). The thermometry scan was repeated every 6 s.</p>
<div id="fig5"><a href="http://www.visualaseinc.com/wp-content/uploads/2010/03/gr5.jpg" rel="shadowbox[post-656];player=img;"><img class="alignnone size-full wp-image-657" style="margin-top: 20px; margin-bottom: 20px;" title="treating prostate cancer minimally invasive" src="http://www.visualaseinc.com/wp-content/uploads/2010/03/gr5.jpg" alt="treating prostate cancer minimally invasive" width="347" height="166" /></a></div>
<div><span>Fig. 5</span> <span>(a) Tissue temperature map  measured by magnetic resonance thermometry (echo planar imaging with  multiphase; field of view: 25 × 25 cm; matrix 256 × 256; number of  excitations: 1; repetition time: 545 ms; echo time: 20 ms; flip angle:  20°; slice thickness: 3 mm) during laser ablation; (b) a map of the  tissue volume exceeding the threshold damage for coagulation was  superimposed on the anatomical image, with the pink line measuring the  maximum diameter of the ablated tissue.</span></div>
<p>The MRI thermometry software (Visualase, Inc, Houston, TX,  USA) allowed us to monitor temperature at specific points in the tissue.  The temperature at those points was used as a feedback to control the  laser. During the laser heating, the temperatures at the border of the  rectal wall and urethra were monitored and maintained at safe levels by  shutting down the laser automatically when the temperature at these  critical points exceeded 45 °C. Thermal damage was calculated using an  Arrhenius formula. Temperature and damage maps were superimposed onto  anatomic images (Fig.  5b). Once the desired volume of tissue destruction was achieved,  laser power was stopped.</p></blockquote>
<blockquote><p>The patients were discharged home within 3 h. MR scans performed 2 wk  post-procedure showed no evidence of complications with preservation of  rectum and neurovascular bundles. No adverse effects were noted at ≤1 mo after the procedure.  Six-month follow-up biopsies are pending.</p></blockquote>
<blockquote><p>Outpatient MRI-guided FLT as used in the present study allows for  visualization of the tumor; real-time guidance of the thermal device to  the target; monitoring and control of the zone of ablation and  surrounding tissue during the procedure; and the ability to immediately  confirm the success of the (ablation) and, if necessary, immediately  repeat (ablation). The required skills are common to other minimally  invasive procedures, resulting in a short learning curve for the  surgeon. Refinement of this outpatient procedure may result in an  inexpensive, minimally invasive alternative to current active therapies.  Further trials will be necessary to define the safety and oncologic  efficacy of this therapy, but our early results are promising.</p></blockquote>
<blockquote>
<h3>Acknowledgment</h3>
<p>The authors would  like to thank Drs. Ashok Gowda and Roger McNichols of <a title="Focal ablation in prostate" href="http://www.visualaseinc.com" target="_blank">Visualase</a> Inc.,  Houston, Texas, USA, for generously supplying the laser and magnetic  resonance thermometry system and for their technical support of this  study.</p></blockquote>
<div align="right" style="float:right;padding:5px 0xp 0px 5px;"><a name="fb_share" type="button" share_url="http://www.visualaseinc.com/2010/prostate-focal-ablation-mri/"></a></div>]]></content:encoded>
			<wfw:commentRss>http://www.visualaseinc.com/2010/prostate-focal-ablation-mri/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

